Search

Start Over Keyword Hematopoietic cell transplant

  • SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study

    SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study
    Authors:Joshua A Hill, Fred Hutchinson Cancer CenterMichael J Martens, Medical College of WisconsinJo-Anne H Young, University of Minnesota, MinneapolisKavita Bhavsar, Medical College of WisconsinJianqun Kou, Medical College of WisconsinMin Chen, Medical College of WisconsinLik Wee Lee, Adaptive Biotechnologies CorpAliyah Baluch, H. Lee Moffitt Cancer Center and Research InstituteMadhav Dhodapkar, Emory UniversityRyotaro Nakamura, City of Hope, Duarte, CA, USAKristin Peyton, The Emmes CompanyZainab Shahid, Memorial Sloan Kettering Cancer Center, New YorkPaul Armistead, University of North CarolinaPeter Westervelt, Washington UniversityJohn McCarty, Virginia Commonwealth UniversityJoseph McGuirk, University of KansasMehdi Hamadani, Medical College of WisconsinSusan DeWolf, Memorial Sloan Kettering Cancer Center, New YorkKinga Hosszu, Memorial Sloan Kettering Cancer Center, New YorkElad Sharon, National Cancer Institute, BethesdaAshley Spahn, National Marrow Donor Program/Center for International Blood and Marrow Transplant Research, MinneapolisAmir A Toor, Virginia Commonwealth UniversityStephanie Waldvogel, National Marrow Donor Program/Center for International Blood and Marrow Transplant Research, Minneapolis, MN, USALee M Greenberger, The Leukemia and Lymphoma Society, Rye Brook, New York, NY, USAJeffrey J Auletta, National Marrow Donor Program/Center for International Blood and Marrow Transplant Research, Minneapolis, MN, USAMary M Horowitz, Center for International Blood and Marrow Transplantation Research, Medical College of Wisconsin, Milwaukee, WI, USAMarcie L Riches, Center for International Blood and Marrow Transplantation Research, Medical College of Wisconsin, Milwaukee, WI, USAMiguel-Angel Perales, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Date:2023
    Publisher:ELSEVIER
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • The Impact of Donor Type on Outcomes and Cost of Allogeneic Hematopoietic Cell Transplantation for Pediatric Leukemia: A Merged Center for International Blood and Marrow Transplant Research and Pediatric Health Information System Analysis

    The Impact of Donor Type on Outcomes and Cost of Allogeneic Hematopoietic Cell Transplantation for Pediatric Leukemia: A Merged Center for International Blood and Marrow Transplant Research and Pediatric Health Information System Analysis
    Authors:Staci Arnold, Emory UniversityRuta Brazauskas, Medical College of WisconsinNaya He, Medical College of WisconsinYimei Li, University of PennsylvaniaMatt Hall, Children’s Hospital AssociationYoshiko Atsuta, Japanese Data Ctr Hematopoiet Cell TransplantatJignesh Dalal, Rainbow Babies & Children’s HospitalTheresa Hahn, Roswell Park Cancer Institute, BuffaloNandita Khera, Mayo ClinicCarmem Bonfim, University of ParanaShahrukh Hashmi, King Faisal Specialist Hospital and Research Center, RiydahSusan Parsons, Tufts Medical CenterWilliam A Wood, University of North CarolinaAmir Steinberg, Mount Saini HospitalCésar O Freytes, Texas Transplant InstituteChristopher E Dandoy, University of CincinnatiDavid Marks, University Hospitals Bristol NHS TrustHillard M Lazarus, Case Western Reserve UniversityHisham Abdel-Azim, University of Southern CaliforniaMenachem Bitan, Tel-Aviv Sourasky Medical CenterMiguel Angel Diaz, Hospital Infantil Universitario Nino JesusRichard F Olsson, Karolinska InstitutetUsama Gergis, Thomas Jefferson UniversityAdriana Seber, Hospital Samaritano de São PauloBaldeep Wirk, Penn State Cancer InstituteFred C LeMaistre, Sarah Cannon Blood Cancer NetworkCelalettin Ustun, Rush UniversityChristine Duncan, Boston Childrens HospitalDavid Rizzieri, Duke UniversityDavid Szwajcer, University of ManitobaFranca Fagioli, Regina Margherita Children HospitalHaydar Frangoul, The Children’s Hospital at TriStar Centennial Medical CenterJennifer M Knight, Medical College of WisconsinRammurti T Kamble, Baylor College of MedicinePaulette Mehta, Central Arkansas Veterans Healthcare SystemRaquel Schears, University of Central FloridaPrakash Satwani, Columbia UniversityMichael A Pulsipher, University of Southern CaliforniaRichard Aplenc, University of PennsylvaniaWael Saber, Medical College of Wisconsin
    Date:2020
    Publisher:ELSEVIER SCIENCE INC
    Publication Version:Author Accepted Manuscript (After Peer Review)
    License:Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

  • Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease

    Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease
    Authors:Mark C. Walters, University of California San FranciscoLaura M. De Castro, University of PittsburghKeith M. Sullivan, Duke UniversityLakshmanan Krishnamurti, Emory UniversityNaynesh Kamani, AABBChristopher Bredeson, University of OttawaDonna Neuberg, Dana Farber Cancer InstituteKathryn L. Hassell, University of ColoradoStephanie Farnia, National Marrow Donor ProgramAndrew Campbell, University of MichiganEffie Petersdorf, Fred Hutchinson Cancer Research Center
    Date:2016
    Publisher:Elsevier
    Publication Version:Final Published Version
    License:Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International